Inhibikase Therapeutics (IKT)
NASDAQ:IKT
Want to see IKT full AI Analyst Report?
Technical Sentiment
Overall Consensus
Strong Buy
15Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Inhibikase Therapeutics’s (IKT) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Inhibikase Therapeutics is a Sell.
Inhibikase Therapeutics’s (IKT) 20-Day exponential moving average is 1.75, while Inhibikase Therapeutics’s (IKT) share price is $1.83, making it a Buy.
Inhibikase Therapeutics’s (IKT) 50-Day exponential moving average is 1.77, while Inhibikase Therapeutics’s (IKT) share price is $1.83, making it a Buy.
Inhibikase Therapeutics (IKT) Pivot Points
Classic
1.53
1.60
1.65
1.72
1.77
1.84
1.89
Fibonacci
1.60
1.65
1.67
1.72
1.77
1.79
1.84
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Inhibikase Therapeutics (IKT) Moving Averages
MA5
1.75Buy
1.76Buy
MA10
1.74Buy
1.75Buy
MA20
1.72Buy
1.75Buy
MA50
1.80Buy
1.77Buy
MA100
1.73Buy
1.75Buy
MA200
1.70Buy
1.76Buy
Inhibikase Therapeutics’s (IKT) 10-Day exponential moving average is 1.75, while Inhibikase Therapeutics’s (IKT) share price is $1.83, making it a Buy.
Inhibikase Therapeutics’s (IKT) 100-Day exponential moving average is 1.75, while Inhibikase Therapeutics’s (IKT) share price is $1.83, making it a Buy.
Inhibikase Therapeutics’s (IKT) stock price is $1.83 and Inhibikase Therapeutics’s (IKT) 50-day simple moving average is 1.80, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.83 and Inhibikase Therapeutics’s (IKT) 100-day simple moving average is 1.73, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.83 and Inhibikase Therapeutics’s (IKT) 200-day simple moving average is 1.70, creating a Buy signal.
Inhibikase Therapeutics (IKT) Technical Indicators
RSI (14)
54.70
Neutral
STOCH (9,6)
62.05
Neutral
STOCHRSI (14)
75.82
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
12.06
Buy
Williams %R
-7.14
Sell
CCI (14)
101.57
Sell
ATR (14)
0.11
-
Ultimate Oscillator
51.27
Neutral
ROC
8.93
Buy
Inhibikase Therapeutics’s (IKT) Relative Strength Index (RSI) is 54.70, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Trend Strength Indicator (ADX) is 12.06, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) Commodity Channel Index (CCI) is 101.57, creating a Sell signal.
Inhibikase Therapeutics’s (IKT) Price Rate of Change (ROC) is 8.93, creating a Buy signal.
FAQ
Is IKT a Buy, Hold, or Sell?
Based on IKT’s technical indicators, IKT is a Strong Buy.
What is IKT’s RSI (14)?
IKT’s RSI (14) is 54.70, which suggests IKT is a Neutral.
What is IKT’s MACD?
IKT’s MACD is -0.02, which suggests IKT is a Sell.
What is IKT’s 5-day moving average?
IKT’s 5-day moving average is 1.75, which suggests IKT is a Buy.
What is IKT’s 20-day moving average?
IKT 20-day moving average is 1.72, which suggests IKT is a Buy.
What is IKT’s 50-day moving average?
IKT’s 50-day moving average is 1.80, which suggests IKT is a Buy.
What is IKT’s 200-day moving average?
IKT’s 200-day moving average is 1.70, which suggests IKT is a Buy.
What is IKT’s Williams % R (14)?
IKT’s Williams % R (14) is -7.14, which suggests IKT is a Sell.
What is IKT’s CCI (14)?
IKT’s CCI (14) is 101.57, which suggests IKT is a Sell.